Nevada Legislature Passes 340B Nondiscrimination Bill

Nevada state capitol
Nevada lawmakers passed and sent to the governor a bill to stop PBM and insurance company discrimination against 340B covered entities.

Nevada lawmakers have unanimously passed and sent to the state’s governor legislation prohibiting pharmacy benefit managers and health insurance carriers from discriminating against 340B covered entities and their contract pharmacies.

The state Assembly voted 42-0 on June 3 and the

Read More »

News Alert

Bausch Health Tightens its Conditions on 340B Pricing to All Covered Entities

Bausch Health
Bausch Health today tightened its conditions on 340B pricing involving deliveries to contract pharmacies.

Bausch Health this morning updated its conditions on 340B pricing involving deliveries to contract pharmacies to all covered entities. It is the fifth drug maker this month to either impose such conditions for the first time (Organon and

Read More »

News Alert

Exelixis Extends 340B Price Conditions to Hospitals’ Wholly Owned Contract Pharmacies

Exelixis
Exelixis extended its conditions on 340B pricing to contract pharmacies that are wholly owned or under common ownership with a hospital covered entity.

Biopharmaceutical manufacturer Exelixis said today it is extending its conditions on 340B pricing to contract pharmacies that are wholly owned or under common ownership with a hospital covered entity. The change is effective June 26.

Exelixis announced the change in

Read More »

News Alert

Teva Is the 23rd Drug Maker to Impose Limits on 340B Contract Pharmacies

Teva
The final HRSA manufacturer 340B program audit conducted in fiscal year 2023 had no adverse findings for Teva Pharmaceuticals.

Drug manufacturer Teva today became the 23rd drug manufacturer to impose conditions on 340B pricing involving delivery to contract pharmacies.

Covered entities reported getting Teva’s notice by email around 1:00 p.m. Eastern. It said effective July 5:

    Read More »

    Final Connecticut Bill Excludes Both 340B Transparency and Contract Pharmacy Provisions

    Connecticut Senate
    The Connecticut Senate gave final passage to legislation that bars PBM discrimination against 340B entities. But it does not bar manufacturers from limiting contract pharmacy use in 340B nor require 340B entities to report on their program savings.

    Connecticut will not, after all, be the first state to require 340B covered entities to file reports on their 340B program savings and how they use them, under a bill the state Senate gave final passage to late last night.

    Read More »

    Protest Held at Indiana Congressman’s State Office Against His 340B Hospital Reporting Bill

    AHF Bucshon
    AIDS Healthcare Foundation advocates marched yesterday outside U.S. Rep. Larry Bucshon's (R-Ind.) Terre Haute, Ind., office to protest Bucshon's bill to impose reporting requirements on 340B hospitals and potentially other covered entities.

    AIDS Healthcare Foundation staged a march yesterday outside U.S. Rep. Larry Bucshon’s (R-Ind.) Terre Haute office to protest his bill that would require 340B disproportionate share hospitals to report data about patients who get 340B drugs, spending on charity care,

    Read More »

    Merck Sues to Stop Medicare Drug Price Negotiation

    Merck
    Merck has sued to stop the federal government from negotiating prices for certain high expenditure, single source Medicare Part B or Part D drugs

    Federal Medicare drug price negotiation “is tantamount to extortion” and must be struck down as unconstitutional, drug manufacturer Merck told a federal district court yesterday.

    Merck on Tuesday became the first drug maker to sue to stop the federal government

    Read More »

    CMS Creates New Group to Lead Medicaid Managed Care Policy

    CMS
    CMS has created a new group within the CMS Center for Medicaid and CHIP Services to develop and manage federal Medicaid managed care policy.

    The U.S. Centers for Medicare & Medicaid Services (CMS) said this week it has created a new unit within the CMS Center for Medicaid and CHIP Services (CMCS) to develop and manage federal Medicaid managed care policy.

    CMS announced the

    Read More »

    News Alert

    Connecticut Looks Like It Will Be First State to Require 340B Covered Entity Reporting

    Connecticut state capitol
    Connecticut state senators introduced a bill that would implement annual 340B provider reporting requirements shortly after a health office reporting to the governor proposed similar legislation.

    Connecticut lawmakers are expected soon to pass a significantly revised version of Gov. Ned Lamont’s (D) health care cost reduction bill stripped of language that would have barred drug manufacturers from limiting use of contract pharmacies and imposing other conditions

    Read More »

    Louisiana Is Poised to be Second State to Enact 340B Contract Pharmacy Law

    Louisiana state capitol
    Louisiana Gov. John Bel Edwards (D) is expected to sign a bill prohibiting drug company limits on 340B contract pharmacy relationships and pharmacy benefit manager encroachment on health care providers’ 340B program revenue.

    The Louisiana Senate voted unanimously Sunday to pass and send to Gov. John Bel Edwards (D) a bill prohibiting drug manufacturer limits on 340B contract pharmacy relationships and pharmacy benefit manager encroachment on health care providers’ 340B program revenues.

    Edwards

    Read More »
    Generic selectors
    Exact matches only
    Search in title
    Search in content
    Post Type Selectors
    ×

    *Sign up for news summaries and alerts from 340B Report

    Site Footer Live